Antibody-Engineered Nanoparticles Selectively Inhibit Mesenchymal Cells Isolated from Patients with Chronic Lung Allograft Dysfunction - Concepedia

Concepedia

Publication | Closed Access

Antibody-Engineered Nanoparticles Selectively Inhibit Mesenchymal Cells Isolated from Patients with Chronic Lung Allograft Dysfunction

61

Citations

38

References

2014

Year

Emanuela Cova, Miriam Colombo, Simona Inghilleri, Monica Morosini, Simona Miserere, Jesus Peñaranda-Avila, Benedetta Santini, Davide Piloni, Sara Magni, Furio Gramatica,

Abstract

These findings demonstrate the effectiveness of our nanoparticles in inhibiting MCs and open new perspectives for a local treatment of chronic lung allograft dysfunction.

References

	Year	Citations

Page 1